Find Reports
Select Report Type
Reimbursement Review
Displaying 826 - 850 of 1426
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| AbataceptOpens in new tab | Orencia | Abatacept | Arthritis, rheumatoid | List with clinical criteria and/or conditions | Complete | SR0299-000 | |||
| EculizumabOpens in new tab | Soliris | Eculizumab | Hemolytic Uremic Syndrome, Atypical | Do not list | Complete | SR0304-000 | |||
| AdalimumabOpens in new tab | Humira | Adalimumab | Arthritis, juvenile idiopathic | List with clinical criteria and/or conditions | Complete | SR0308-000 | |||
| NebivololOpens in new tab | Bystolic | Nebivolol | Hypertension | Do not list at the submitted price | Complete | SR0307-000 | |||
| Tykerb Letrozole for Metastati...Opens in new tab | Tykerb (in combination with Letrozole) | Lapatinib | Metastatic Breast Cancer | Do not reimburse | Complete | PC0019-000 | |||
| TelaprevirOpens in new tab | Incivek | Telaprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0311-000 | |||
| BoceprevirOpens in new tab | Victrelis | Boceprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0312-000 | |||
| TelaprevirOpens in new tab | Incivek | Telaprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0305-000 | |||
| BoceprevirOpens in new tab | Victrelis | Boceprevir | Hepatitis C, chronic | List with criteria/condition | Complete | SF0303-000 | |||
| Palonosetron hydrochlorideOpens in new tab | Aloxi (injection) | Palonosetron hydrochloride | Chemotherapy-induced nausea and vomiting | Do not list at the submitted price | Complete | SR0293-000 | |||
| Elvitegravir/ Cobicistat/ Em...Opens in new tab | Stribild | Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Disoproxil Fumarate | HIV infection | List with criteria/condition | Complete | SR0301-000 | |||
| Glycopyrronium bromideOpens in new tab | Seebri | Glycopyrronium bromide | Chronic obstructive pulmonary disease | List with criteria/condition | Complete | SR0300-000 | |||
| Xalkori for Advanced NSCLC - R...Opens in new tab | Xalkori | Crizotinib | Advanced or Metastatic Non-Small Cell Lung Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0017-000 | |||
| Palonosetron hydrochlorideOpens in new tab | Aloxi (capsule) | Palonosetron hydrochloride | Chemotherapy-induced nausea and vomiting | Do not list | Complete | SR0294-000 | |||
| PirfenidoneOpens in new tab | Esbriet | Pirfenidone | Idiopathic pulmonary fibrosis | Do not list | Complete | SR0292-000 | |||
| Doxycycline monohydrateOpens in new tab | Apprilon | Doxycycline monohydrate | Rosacea | Do not list | Complete | SR0279-000 | |||
| Collagenase clostridium histol...Opens in new tab | Xiaflex | Collagenase clostridium histolyticum | Dupuytren’s contracture | List with criteria/condition | Complete | SR0287-000 | |||
| Velcade for Multiple Myeloma -...Opens in new tab | Velcade | Bortezomib | Multiple Myeloma | Reimburse | Complete | PC0016-000 | |||
| Afinitor for Advanced Breast -...Opens in new tab | Afinitor | Everolimus | Advanced Breast Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0014-000 | |||
| IvacaftorOpens in new tab | Kalydeco | Ivacaftor | Cystic fibrosis, G551D mutation | List with criteria/condition | Complete | SR0291-000 | |||
| Grass Pollen Allergen ExtractOpens in new tab | Oralair | Grass Pollen Allergen Extract | Allergic rhinitis | List with criteria/condition | Complete | SR0290-000 | |||
| ApixabanOpens in new tab | Eliquis | Apixaban | Thromboembolic events prevention, (atrial fibrillation) | List with clinical criteria and/or conditions | Complete | SR0288-000 | |||
| Inlyta for metastatic renal ce...Opens in new tab | Inlyta | Axitinib | Metastatic Renal Cell Carcinoma | Reimburse | Complete | PC0013-000 | |||
| Treanda for Chronic Lymphocyti...Opens in new tab | Treanda | Bendamustine hydrochloride | Chronic Lymphocytic Leukemia (first-line) | Reimburse with clinical criteria and/or conditions | Complete | PC0011-000 | |||
| TolvaptanOpens in new tab | Samsca | Tolvaptan | Hyponatremia, non-hypovolemic | Do not list | Complete | SR0283-000 |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 826 - 850 of 2138
Please scroll or swipe to the right to view the full content.
Provisional Funding Algorithm
Displaying 76 - 81 of 81